· Desk editor: Nadia Hassan · · Single source ·Updated

Farmer Julianne McLean hopes MND trial offers new hope

A Sunshine Coast farmer diagnosed with motor neurone disease in August hopes to join a national clinical trial launching next year.

Farmer hopes MND trial could give her more time with family
File photo Farmer hopes MND trial could give her more time with family Photo: ABC News Australia

Patient seeks therapy access

In August of this year, Julianne McLean, a 49-year-old cattle farmer based in Kilkivan, received a diagnosis of motor neurone disease. Her symptoms began as discomfort in her left leg before progressing to difficulty walking and foot drop. She now faces spinal and voice degeneration while managing the physical demands of her farm. This ailment impacts nerve cells within the brain and spinal cord that control movement.

Trial details and research

Sunshine Coast University Hospital director of neurology Antony Winkel explained that life expectancy after diagnosis is typically two to three years. A new protein-based therapy developed over 25 years of University of Queensland research will advance to phase 2 next year. The 75-person trial will roll out at hospitals in Brisbane, Perth, Sydney, Newcastle and the Sunshine Coast. UQ's Queensland Brain Institute aims to commercialise findings through a biotechnology company called NuNerve.

Family braces for future

MND Queensland chief executive Stacey Thorpe described the announcement as an encouraging development given limited treatment options currently available. Ms McLean and her husband Angus are preparing for a difficult period as her strength continues to deteriorate. She stated that losing hope is the first consequence of receiving a terminal diagnosis with no cure. The trial recruitment phase is ongoing and families await further updates on participant selection.

Reported by one outlet

Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.

Reported by

1 independent outlet. Headline as published. Links open the original report.